Hare
HomeInsights

INDUSTRY:

Pharma

TOPIC:

Business & People, Manufacturers & Providers

TITLE:

NICE: New guidance on treatments for arthritis

BRIEF:

The National Institute for Care and Health Excellence (NICE) has recently published new guidance on abatacept, adalimumab, etanercept and tocilizumab as possible treatment for polyarticular juvenile idiopathic arthritis (JIA).

LEGAL IMPLICATIONS:

BUSINESS IMPLICATIONS:

Special Report

In an unexpected move, just before the end of 2011, ...

Case Study

Improving expenditure efficiency has been, for a ver...

Your Portal Link to Mass Media Universe.

Valuable Quarterly Romanian Market Analysis.

Ask the analyst

Tailor-made advice for you

Feature Company